ITUA20163937A1 - Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso. - Google Patents

Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.

Info

Publication number
ITUA20163937A1
ITUA20163937A1 ITUA2016A003937A ITUA20163937A ITUA20163937A1 IT UA20163937 A1 ITUA20163937 A1 IT UA20163937A1 IT UA2016A003937 A ITUA2016A003937 A IT UA2016A003937A IT UA20163937 A ITUA20163937 A IT UA20163937A IT UA20163937 A1 ITUA20163937 A1 IT UA20163937A1
Authority
IT
Italy
Prior art keywords
administration
ingredients
vehicle
same
compositions containing
Prior art date
Application number
ITUA2016A003937A
Other languages
English (en)
Inventor
Fabiano Frosio
Alessandro Pisani
Original Assignee
Pharcoterm S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharcoterm S R L filed Critical Pharcoterm S R L
Priority to ITUA2016A003937A priority Critical patent/ITUA20163937A1/it
Publication of ITUA20163937A1 publication Critical patent/ITUA20163937A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
ITUA2016A003937A 2016-05-30 2016-05-30 Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso. ITUA20163937A1 (it)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITUA2016A003937A ITUA20163937A1 (it) 2016-05-30 2016-05-30 Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A003937A ITUA20163937A1 (it) 2016-05-30 2016-05-30 Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.

Publications (1)

Publication Number Publication Date
ITUA20163937A1 true ITUA20163937A1 (it) 2017-11-30

Family

ID=57045303

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A003937A ITUA20163937A1 (it) 2016-05-30 2016-05-30 Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.

Country Status (1)

Country Link
IT (1) ITUA20163937A1 (it)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003090801A1 (en) * 2002-04-24 2003-11-06 Le Groupe Lysac Inc. Polysaccharides compositions as biodegradable absorbent materials
WO2003105882A1 (en) * 2002-06-13 2003-12-24 Novartis Nutrition Ag Composition comprising viscous fibers and viscosity-lowering proteins
WO2016028968A1 (en) * 2014-08-20 2016-02-25 Professional Compounding Centers Of America Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003090801A1 (en) * 2002-04-24 2003-11-06 Le Groupe Lysac Inc. Polysaccharides compositions as biodegradable absorbent materials
WO2003105882A1 (en) * 2002-06-13 2003-12-24 Novartis Nutrition Ag Composition comprising viscous fibers and viscosity-lowering proteins
WO2016028968A1 (en) * 2014-08-20 2016-02-25 Professional Compounding Centers Of America Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "Glucomannan", 31 December 2002 (2002-12-31), XP055112171, Retrieved from the Internet <URL:http://www.konjacfoods.com/gum.htm> [retrieved on 20140404] *
DATABASE GNPD [online] MINTEL; March 2005 (2005-03-01), "Appetite Fulfilling Dietary Supplement", XP002766586, Database accession no. 10210799 *

Similar Documents

Publication Publication Date Title
IL286693A (en) Combined stress response modulator compounds, preparations containing them and their uses
DOP2019000117A (es) Nuevos derivados de quinolina
ZA201906451B (en) 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
IL262020B (en) Grisiofulvin compound, preparations containing it and its uses
EA201892822A1 (ru) Новые антибактериальные соединения
TR201901228T4 (tr) Vortioksetin piroglutamat.
EP3449924A4 (en) COMPOSITION, ACTIVE SITE OF CROCINES, AND USES THEREOF
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP3539978A4 (en) NKX3.2 FRAGMENT AND PHARMACEUTICAL COMPOSITION WITH IT AS THE ACTIVE INGREDIENT
EP3670500A4 (en) CHEMICAL COMPOUND, PHARMACEUTICAL COMPOSITION OF IT, CORRESPONDING USE AND APPLICATION
WO2016130581A3 (en) Combination cancer therapy
CA2904166C (en) Formulations with reduced oxidation
WO2015003082A3 (en) Volatile organic compound formulations having antimicrobial activity
MX2018014790A (es) Formulacion combinada de tres compuestos antivirales.
EP3398608A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND TREATMENT OF CANCER OR CANCER METASTASES WITH PSTL1-PRTEIN AS AN ACTIVE SUBSTANCE
PH12019502145A1 (en) Agent for preventing myopia, treating myopia, and/or preventing myopia progression comprising tiotropium as active ingredient
EP3492489A4 (en) NOVEL AIMP1 PROTEIN FRAGMENT AND SKIN PROTECTION COMPOSITION CONTAINING THE SAME AS ACTIVE INGREDIENT
WO2017087914A3 (en) Urea biosensors and uses thereof
EP3404054A4 (en) PHARMACEUTICAL COMPOSITION BASED ON 5-DODECANOLID, PREPARATION AND USE THEREOF
EA201791483A1 (ru) Фармацевтическая композиция для лечения микоза
EP3323411A4 (en) Composition for inhibiting angiogenesis containing nanoparticle-vitreous body-based protein complex as active ingredient, and use thereof
ITUA20163937A1 (it) Veicolo per la somministrazione di principi attivi e/o ingredienti funzionali, e composizioni contenenti lo stesso.
EA202091403A1 (ru) Производные 2-оксо-1-пирролидинилимидазотиадиазола
WO2015112168A3 (en) Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
EP3542797A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DYRK-RELATED ILLNESSES USING PYRIDINE-BASED COMPOUNDS AS AN ACTIVE SUBSTANCE